Clover Health Investments, Corp. (CLOV)

Clover Health Investments Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	1,853	2,034	3,477	1,472	672.89	462.27
Revenue Growth (YoY)	-36.64%	-41.50%	136.19%	118.76%	45.56%	59.06%
Cost of Revenue	1,564	1,769	3,360	1,662	572.95	457.22
Gross Profit	289.24	264.57	116.25	-189.81	99.93	5.04
Selling, General & Admin	420.91	444.73	486.64	445.75	192.09	187.33
Other Operating Expenses	26.97	28.39	1.26	1.44	0.56	0.91
Operating Expenses	447.88	473.11	487.9	447.18	192.64	188.24
Operating Income	-158.64	-208.54	-371.65	-636.99	-92.71	-183.2
Interest Expense / Income	0.01	0.01	1.33	3.19	35.99	23.16
Other Expense / Income	1.28	4.81	-33.41	-52.43	7.7	157.38
Pretax Income	-159.93	-213.36	-339.57	-587.76	-136.39	-363.74
Net Income	-159.93	-213.36	-339.57	-587.76	-136.39	-363.74
Shares Outstanding (Basic)	486	482	476	413	89	88
Shares Outstanding (Diluted)	567	482	476	413	89	88
Shares Change	0.15%	1.25%	15.34%	365.57%	0.98%	109.06%
EPS (Basic)	-0.34	-0.44	-0.71	-1.42	-1.54	-4.14
EPS (Diluted)	-0.34	-0.44	-0.71	-1.42	-1.54	-4.14
Free Cash Flow	-169.75	-116.46	-290.82	-283.05	-119.19	-159.9
Free Cash Flow Per Share	-0.35	-0.24	-0.61	-0.69	-1.34	-1.82
Gross Margin	15.61%	13.01%	3.34%	-12.89%	14.85%	1.09%
Operating Margin	-8.56%	-10.25%	-10.69%	-43.27%	-13.78%	-39.63%
Profit Margin	-8.63%	-10.49%	-9.77%	-39.93%	-20.27%	-78.69%
Free Cash Flow Margin	-9.16%	-5.73%	-8.36%	-19.23%	-17.71%	-34.59%
EBITDA	-157.37	-210.85	-337.05	-583.32	-99.85	-340.03
EBITDA Margin	-8.49%	-10.37%	-9.69%	-39.63%	-14.84%	-73.56%
Depreciation & Amortization	2.55	2.51	1.19	1.25	0.56	0.55
EBIT	-159.92	-213.35	-338.23	-584.56	-100.4	-340.58
EBIT Margin	-8.63%	-10.49%	-9.73%	-39.71%	-14.92%	-73.68%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).